Description: Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. The company provides APIs and intermediates, and formulations; and dimethyl ether gas and a-chloropropionyl chloride chemical products. It is also involved in the contract research, manufacture, and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc. The company was founded in 1995 and is based in Jingmen, China.
Home Page: www.biocause.com
No. 122 Yangwan Road
Jingmen,
448000
China
Phone:
86 72 4222 3339
Officers
| Name | Title |
|---|---|
| Mr. Qun Liang | General Manager |
| Mr. Ting Hao Yi | Financial Director |
| Mr. Jian Gao | Board Secretary |
| Mr. Zhenghua Huang | Deputy General Manager |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 53.4324 |
| Price-to-Book MRQ: | 2.5947 |
| Price-to-Sales TTM: | 12.5255 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1012 |